Drug Major Sun Pharmaceuticals has launched of generic Pantoprazole Sodium Delayed Release (DR) Tablets, 40 mg in the market. The drug is used for treating oesophagus ailments.
Sun Pharmaceuticals has launched the drug after the commercial launch by Teva Pharmaceutical Industries and Wyeth’s generic Pantoprazole Sodium tablets product.
This strength of Pantoprazole Sodium has annual sales of around 2.3 billion dollar in the US. Its marketing partner Caraco Pharmaceutical Laboratories is selling the product. The company had received a USFDA approval for these tablets in Sep 2007.